GZD824 is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC₅₀ of 0.34 nM and 0.68 nM, respect ively.

Item Number: BIOV2795-25
Unit of Measure: 25 MG
https://grogg-prod.braintec.cloud/web/image/product.template/923813/image_1920?unique=cdbbe2a

574.00 CHF 574.0 CHF 574.00 CHF

574.00 CHF

Not Available For Sale

    This combination does not exist.

    Current delivery time on request

    Manufacturer: BIOVISION
    Manufacturer Number: 2795-25
    Storage Temperature: Freezer (-20)

    GZD824 is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC₅₀ of 0.34 nM and 0.68 nM, respect ively.